Enzolytics Inc (ENZC)

[falon]

Agreed,

We are to early in the process for a buy out.

Down the road once some of our product hit the marketplace then the possibility exist.

Even then how do you value something with virtually unlimited solutions for many different diseases.

The Company is also applying Artificial Intelligence [AI] to scan the hundreds of thousands of isolates that exist in 14 other prevalent viruses, ranging from influenza to Rabies to Ebola. Using the Company's proprietary technique for producing fully human monoclonal antibodies directed against these infectious diseases, the Company will produce multiple neutralizing monoclonal antibodies against these viruses. The significance of this approach is well recognized by experts in virology due to the ability of all viruses to mutate and render ineffective initially developed therapeutics.